These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
619 related articles for article (PubMed ID: 23128378)
1. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer. Ye S; Yang W; Wang Y; Ou W; Ma Q; Yu C; Ren J; Zhong G; Shi H; Yuan Z; Su X; Zhu W Int J Mol Med; 2013 Jan; 31(1):33-42. PubMed ID: 23128378 [TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumor effect of cisplatin in human NSCLC cells by tumor suppressor LKB1. Ou W; Ye S; Yang W; Wang Y; Ma Q; Yu C; Shi H; Yuan Z; Zhong G; Ren J; Zhu W; Wei Y Cancer Gene Ther; 2012 Jul; 19(7):489-98. PubMed ID: 22576699 [TBL] [Abstract][Full Text] [Related]
3. [Effects of a protein kinase C inhibitor combined with cisplatin on non-small cell lung cancer]. Gao ZQ; Han BH; Sha HF; Shi ZY; Yang XH; Feng JX Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):284-8. PubMed ID: 20646461 [TBL] [Abstract][Full Text] [Related]
4. Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma. Carter CA; Chen C; Brink C; Vincent P; Maxuitenko YY; Gilbert KS; Waud WR; Zhang X Cancer Chemother Pharmacol; 2007 Feb; 59(2):183-95. PubMed ID: 16724239 [TBL] [Abstract][Full Text] [Related]
5. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway. Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220 [TBL] [Abstract][Full Text] [Related]
6. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin. Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer. Fahham D; Weiss ID; Abraham M; Beider K; Hanna W; Shlomai Z; Eizenberg O; Zamir G; Izhar U; Shapira OM; Peled A; Wald O J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1167-1175.e1. PubMed ID: 22925564 [TBL] [Abstract][Full Text] [Related]
8. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells. Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357 [TBL] [Abstract][Full Text] [Related]
9. Metabolic approach to the enhancement of antitumor effect of chemotherapy: a key role of acetyl-L-carnitine. Pisano C; Vesci L; Milazzo FM; Guglielmi MB; Foderà R; Barbarino M; D'Incalci M; Zucchetti M; Petrangolini G; Tortoreto M; Perego P; Zuco V; Orlandi A; Passeri D; Carminati P; Cavazza C; Zunino F Clin Cancer Res; 2010 Aug; 16(15):3944-53. PubMed ID: 20562210 [TBL] [Abstract][Full Text] [Related]
10. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents. Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549 [TBL] [Abstract][Full Text] [Related]
11. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Katiyar SK; Meeran SM; Katiyar N; Akhtar S Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer. Xie CY; Xu YP; Jin W; Lou LG Anticancer Drugs; 2012 Aug; 23(7):698-705. PubMed ID: 22441567 [TBL] [Abstract][Full Text] [Related]
13. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer. Zhu K; Fang W; Chen Y; Lin S; Chen X Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445 [TBL] [Abstract][Full Text] [Related]
14. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo]. Zhou YL; Hu WX; Lü YP; Qiu LN; Wang WS; Yang ZY; Liu JD; Rao GW Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803 [TBL] [Abstract][Full Text] [Related]
15. A novel combination of TRAIL and doxorubicin enhances antitumor effect based on passive tumor-targeting of liposomes. Guo L; Fan L; Ren J; Pang Z; Ren Y; Li J; Wen Z; Jiang X Nanotechnology; 2011 Jul; 22(26):265105. PubMed ID: 21586819 [TBL] [Abstract][Full Text] [Related]
16. Atorvastatin sensitizes human non-small cell lung carcinomas to carboplatin via suppression of AKT activation and upregulation of TIMP-1. Chen J; Lan T; Hou J; Zhang J; An Y; Tie L; Pan Y; Liu J; Li X Int J Biochem Cell Biol; 2012 May; 44(5):759-69. PubMed ID: 22305890 [TBL] [Abstract][Full Text] [Related]
17. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells. Hu Z; Zeng Q; Zhang B; Liu H; Wang W Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870 [TBL] [Abstract][Full Text] [Related]
18. Effects of polyphyllin I on growth inhibition of human non-small lung cancer cells and in xenograft. Kong M; Fan J; Dong A; Cheng H; Xu R Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):827-33. PubMed ID: 20978038 [TBL] [Abstract][Full Text] [Related]
19. Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy. Ling C; Xie Y; Zhao D; Zhu Y; Xiang J; Yang J Cancer Gene Ther; 2012 Oct; 19(10):697-706. PubMed ID: 22863759 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies. Xue X; Sun DF; Sun CC; Liu HP; Yue B; Zhao CR; Lou HX; Qu XJ Lung Cancer; 2012 Jun; 76(3):300-8. PubMed ID: 22261315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]